Study to Compare the Bioavailability, Safety and Tolerability of XM17 in Healthy, Down Regulated Young Women
Clinical trial NCT02592031 · COMPLETED
Trial details
- NCT number
- NCT02592031
- Sponsor
- Merckle GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2009-05-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.